Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-05-10
1991-03-05
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548467, 548492, 548494, 548502, 548503, 548507, A61K 3140, C07D20942, C07D20920, C07D40506
Patent
active
049978454
ABSTRACT:
.beta.-Alkylmelatonins are useful as ovulation inhibitors.
REFERENCES:
patent: 3211744 (1965-10-01), Hofmann et al.
patent: 4087444 (1978-05-01), Flaugh et al.
patent: 4614807 (1986-09-01), Flaugh
Pasini, Chem Abs 60, 14601c (1964).
The Merck Index, (Tenth Edition 1983) 5633.
Chu et al., Endocrinology, 75, 238 (1964).
Ying et al., Endocrinology, 92, 333 (1973).
Chemical Abstracts, 63, 18192a (1965).
Frohn et al., Life Sci., 27, 2043 (1980).
Flaugh et al., J. Med. Chem., 22, 63 (1979) (Flagh III).
Farlow et al., Org. Prep. and Proc. Int., 13(1), 39 (1981).
Misztal Chemical Abstracts, 92, 128645f (1980).
Berch Mark L.
Eli Lilly and Company
Taylor Douglas J.
Whitaker Leroy
LandOfFree
.beta.-alkylmelatonins as ovulation inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .beta.-alkylmelatonins as ovulation inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .beta.-alkylmelatonins as ovulation inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-497106